| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/04/2008 | US20080213286 Composition comprising mastermind domain (MAM) polypeptide for use in treatment of cardiovascular and cell proliferative disorders |
| 09/04/2008 | US20080213279 Blocking Leukocyte Emigration and Inflammation By Interfering With Cd99l2 |
| 09/04/2008 | US20080213276 G-protein coupled receptor specific immunoglobulin for use in treatment of neurodegenerative, spinal cord, psychological disordrers |
| 09/04/2008 | US20080213272 Vegf-related protein |
| 09/04/2008 | US20080213265 Human cytomegalovirus neutralising antibodies and use thereof |
| 09/04/2008 | US20080213256 Less Immunogenic Binding Molecules |
| 09/04/2008 | US20080213237 Antigen Specific Lymphocytes, Compositions Thereof, and Methods for Isolation and Preparation Thereof |
| 09/04/2008 | US20080213235 Adipose Tissue Stem Cells, Perivascular Cells and Pericytes |
| 09/04/2008 | US20080213233 Using vector transfer to preferential gene sequence into cells; treating nervous system, cell proliferative, muscle, kidney and pancreatic disorders |
| 09/04/2008 | US20080213232 Radial Glial Cells Promote Nerve Regeneration and Functional Recovery Following Spinal Cord Injury |
| 09/04/2008 | US20080213231 Self-renewing progenitor cells for use in treating cardiac disease; tissue engineering; tissue repair; regenerative medicine |
| 09/04/2008 | US20080213230 Pluripotent cell culture for propagation of cardiac tissues and treatment of myocardial infarction; tissue engineering; tissue repair; regenerative medicine |
| 09/04/2008 | US20080213228 Using non-adherent stem cells culture to generate osteogenic cells with ability to mineralize matrix; for use in treatment of bone disorders; tissue engineering; tissue repair; regenerative medicine |
| 09/04/2008 | US20080213227 Using animal progenitor cell culture to propagate organ tissues; tissue engineering; tissue repair; regenerative medicine; treating cell proliferative, arthritic, autoimmune, skin and inflammatory disorders |
| 09/04/2008 | US20080213221 Providing mammalian cell contacted with agent and adeno-associated virus (AAV), identifying agent that when contacted with mammalian cell enhances AAV transduction after viral binding to membrane of contacted mammalian cell and before second strand synthesis which yields expressible form of viral genome |
| 09/04/2008 | US20080213217 (2-carbamoyl-5-chloro-1H-indol-3-yl)-[3-((E)-2-cyano-vinyl)-5-methyl-phenyl]-(S)-phosphinic acid methyl ester; Flaviviruses; bioavailability; pharmacokinetics |
| 09/04/2008 | US20080213216 Transgenic lymphocytes comprising expression vector coding Fc receptor for use in identifying modulators for prevention and treatment of ifection and immune system disorders |
| 09/04/2008 | US20080213214 Treating Cardiovascular Tissue |
| 09/04/2008 | US20080213212 Using sialoadhesin specific immunoglobulin as diagnostic and/or therapeutic tool in treatment and prevention of allergic, respiratory, cell proliferative and skin disorders |
| 09/04/2008 | US20080213189 Multifunctional metal-graphite nanocrystals |
| 09/04/2008 | US20080213171 Cancerous disease modifying antibodies |
| 09/04/2008 | US20080213170 Isolated monoclonal antibody produced by the hybridoma; primary tumors and tumor metastases |
| 09/04/2008 | US20080213169 Cytotoxicity mediation of cells evidencing surface expression of CD59 |
| 09/04/2008 | US20080209709 Container uncapping mechanism and method |
| 09/04/2008 | DE102007011606A1 Fiber-tangled structure useful as cell settling material, wound covering, medical implant and carriers for pharmaceutical active substance and for producing depot medicament, comprises fibers made of partially interlaced gelatin material |
| 09/04/2008 | DE102007008890A1 Nukleinsäure, die für eine pflanzliche Adenosin-Nukleosidase kodiert Nucleic acid encoding a plant adenosine nucleosidase |
| 09/04/2008 | CA2679417A1 Method for production of tooth, and tooth produced by the method |
| 09/04/2008 | CA2679178A1 Compositions and methods for treating peripheral vascular diseases |
| 09/04/2008 | CA2678774A1 Treatment of diseases characterized by inflammation |
| 09/04/2008 | CA2677075A1 Method for activation of helper t cell and composition for use in the method |
| 09/04/2008 | CA2675495A1 Methods for improving culture vessel assays |
| 09/04/2008 | CA2672444A1 Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity |
| 09/04/2008 | CA2663522A1 Mdck cell lines supporting viral growth to high titers and bioreactor process using the same |
| 09/03/2008 | EP1964921A2 The high bone mass gene of 11q13.3 |
| 09/03/2008 | EP1964915A1 Blood-brain barrier in vitro model, pathologic blood-brain barrier in vitro model, drug screening method using the same, pathologic blood-brain barrier function analysis method and pathogenesis analysis method |
| 09/03/2008 | EP1964852A1 Anti-ilt7 antibody |
| 09/03/2008 | EP1964850A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 09/03/2008 | EP1964573A2 Method of inducing and/or enhancing an immune response to tumor antigens |
| 09/03/2008 | EP1964572A2 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| 09/03/2008 | EP1963515A2 Installation of genomes or partial genomes into cells or cell-like systems |
| 09/03/2008 | EP1963510A2 Grg23 and grg51 genes conferring herbicide resistance |
| 09/03/2008 | EP1963506A2 Compositions and methods for increasing production of recombinant gamma-carboxylated proteins |
| 09/03/2008 | EP1963493A2 Methods and reagents for genotyping hcv |
| 09/03/2008 | EP1963491A1 A porous membrane device that promotes the differentiation of monocytes into dendritic cells |
| 09/03/2008 | EP1963490A2 Methods for identifying and targeting tumor stem cells based on nuclear morphology |
| 09/03/2008 | EP1963489A1 Multiloop engineered heart muscle tissue |
| 09/03/2008 | EP1963488A1 Dissimilar promoters for gene suppression |
| 09/03/2008 | EP1963487A2 Manipulation of chemical and/or biological species using magnetic field modulators |
| 09/03/2008 | EP1963365A1 Recombinant gelatin particles for cell adhesion |
| 09/03/2008 | EP1962719A2 Media for culturing stem cells |
| 09/03/2008 | EP1907854A4 Monoclonal antibodies, hybridoma cell lines, methods and kits for detecting phytase |
| 09/03/2008 | EP1831351A4 Production from blood of cells of neural lineage |
| 09/03/2008 | EP1715736A4 Polypeptides having xylanase activity and polynucleotides encoding same |
| 09/03/2008 | EP1578957A4 Formable and settable polymer bone composite and method of production thereof |
| 09/03/2008 | EP1430083B1 T1r taste receptors and genes encoding same |
| 09/03/2008 | EP1311708B1 Method for identifying substances useful for treating inflammation using the response element to the ikappabaplha ror receptor |
| 09/03/2008 | EP1291429B1 Glutamine fructose-6-phosphate amidotransferase splice variant and its expression product |
| 09/03/2008 | EP1180159B1 Methods and compositions for lowering the level of tumor necrosis factor (tnf) in tnf-associated disorders |
| 09/03/2008 | EP1161455B1 A novel chimeric protein for prevention and treatment of hiv infection |
| 09/03/2008 | EP1137769B1 Methods for the generation of dna libraries |
| 09/03/2008 | EP1112371B1 Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 09/03/2008 | EP1090300B1 Asssay to predict the success of in-vitro maturation (IVM) |
| 09/03/2008 | EP1002115B2 Universal chloroplast integration and expression vectors and transformed plants |
| 09/03/2008 | EP0852463B1 Myogenic differentiation of human mesenchymal stem cells |
| 09/03/2008 | EP0789575B1 Peripheral nervous system specific sodium channels, dna encoding therefor, drug screening, and methods of making and using thereof |
| 09/03/2008 | CN101258238A Method for activation treatment of antigen-presenting cell |
| 09/03/2008 | CN101258237A Apparatus and methods for preparing tissue grafts |
| 09/03/2008 | CN101258236A Serum-free culture medium for the production of recombinant gonadotropins |
| 09/03/2008 | CN101258166A Antibody combining with STEAP-1 protein and deriving molecule thereof |
| 09/03/2008 | CN101257915A Method of inhibiting angiogenesis by using ephrin B2 |
| 09/03/2008 | CN101257861A Methods and compositions for enhancing vascular access |
| 09/03/2008 | CN101255442A LMP-1 recombinant gland related viral vectors as well as construction method and uses thereof |
| 09/03/2008 | CN101255441A AFP recombinant gland related viral vectors as well as construction method and uses thereof |
| 09/03/2008 | CN101255432A Artificial reconstruction synthetic pesticidal gene as well as encoding protein and use thereof |
| 09/03/2008 | CN101255407A Immortalized rat marrow stroma cell system and preparation method thereof |
| 09/03/2008 | CN101255406A Human ovarian cancer drug-resistant cell strain and culture method thereof |
| 09/03/2008 | CN101255196A Immune globulin single variant antigen bonding land and specificity construction body thereof |
| 09/03/2008 | CN101255195A Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection |
| 09/03/2008 | CN101255194A Rabbit anti-human MK monoclonal antibody as well as hybridoma cell strain and uses thereof |
| 09/03/2008 | CN101255192A Soluble CTLA4 mutant molecules and uses thereof |
| 09/03/2008 | CN100415895C Non-splicing variant of gp 350/220 |
| 09/03/2008 | CN100415889C 阿拉伯木聚糖降解酶 Arabinoxylan degrading enzyme |
| 09/03/2008 | CN100415885C Methods and means for modulating cellulose biosynthesis in fiber producing plants |
| 09/03/2008 | CN100415878C Alpha-amylase with high production capacity |
| 09/03/2008 | CN100415875C Process for preparing self-fibroblast by skin prefibroblast |
| 09/03/2008 | CN100415772C Anti-ErbB2 antibodies |
| 09/03/2008 | CN100415765C Methods for humanizing rabbit monoclonal antibodies |
| 09/02/2008 | US7421105 Method for staining corneocytes, method for preparing corneocytes specimen and skin analysis system |
| 09/02/2008 | US7420102 DNA sequences that reduced bioactive Gibberellins (GA) levels and the height of a plant; transgenic dwarf plants; genes are dominant with regard to the dwarf phenotype so that a dwarf transgenic plant is easy to create |
| 09/02/2008 | US7420050 TGF-β-specific covalently closed antisense molecule |
| 09/02/2008 | US7420048 A GDP (Guanosine diphosphate) dissociation stimulating protein gene containing a nucleotide sequence coding for a specific amino acid sequence; gene useful as an indicator in the prophylaxis, diagnosis and treatment of diseases |
| 09/02/2008 | US7420047 Nucleotide sequence encoding antigenic peptide; induces immune response which does not cause anaphylaxis when administered; safety |
| 09/02/2008 | US7420045 IAPs associated cell cycle proteins, compositions and methods of use |
| 09/02/2008 | US7420043 Reagents for detecting efavirenz |
| 09/02/2008 | US7420042 Soluble neuropilin/growth factor receptor fusion proteins |
| 09/02/2008 | US7419948 Recombinant human Factor IX produced by a transgenic pig having an exogenous DNA stably integrated into its genome that secretes the biologically active Factor into its milk; the factor may be gamma -carboxylated |
| 09/02/2008 | US7419829 Mutated woodchuck posttranscriptional regulatory element (WPRE) sequence having ablated X protein tumorigenic activity; safely used in retroviral and lentiviral vectors to enhance expression levels of heterologous genes or nucleotides |
| 09/02/2008 | US7419828 Compositions and methods for non-targeted activation of endogenous genes |
| 09/02/2008 | US7419827 Neural stem cell culture for prevention and treatment of brain and nervous sytem disorders |
| 09/02/2008 | US7419826 Mutant neurofibromatosis gene of papilloma virus; higher proliferation rate; contacting with drug, hormone, cytokine and detecting change in growth |